DreamPharm Products:
Clin Exp Allergy. 2002 Nov;32(11):1558-65.
Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition.
Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, Wenzel SE.
Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, D104, Denver 80206, Colorado, USA. chuhjc.org
BACKGROUND: Although 15(S)-hydroxyeicosatetraenoic acid (15(S)-HETE), a product of 15-lipoxygenase (15-LO), may be involved in mild to moderate asthma, little is known about its potential roles in severe asthma. OBJECTIVES: This study was performed to evaluate 15(S)-HETE levels in bronchoalveolar lavage fluid (BALF) from severe asthmatics with and without airway eosinophils and from the control groups. In addition, 15-LO protein expression was examined in endobronchial biopsy, while its expression and activation were evaluated in BAL cells. RESULTS: While 15(S)-HETE levels in BALF were significantly higher in all severe asthmatics than normal subjects, severe asthmatics with airway eosinophils had the highest levels compared with mild, moderate asthmatics and normal subjects. 15(S)-HETE levels were associated with tissue eosinophil numbers, sub-basement membrane thickness and BALF tissue inhibitor of metalloproteinase-1 levels, and were accompanied by increased 15-LO expression in bronchial epithelium. In addition, activation of 15-LO was suggested by the increased proportion of 15-LO in the cytoplasmic membrane of alveolar macrophages from severe asthmatics. CONCLUSION: The data suggest that severe asthmatics with persistent airway eosinophils manifest high levels of 15(S)-HETE in BALF, which may be associated with airway fibrosis. It is likely that 15-LO expression and activation by airway cells explain the increased 15(S)-HETE levels.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12569975&dopt=Abstract
Hypertension. 1999 Mar;33(3):806-10.
Distribution of lamellar deformations: implications for properties of the arterial media.
Dobrin PB.
Veterans Affairs Medical Center and Department of Surgery, University of Missouri Health Sciences Center, Columbia, MO 65201, USA. Philip.Dobried.va.gov
Most computations of arterial mechanics treat the wall as a mechanically homogeneous body, but there are no data to support or refute this. To evaluate this assumption, experiments were performed that measured the deformation of 4 elastic lamellae located at 4 equidistant points across the thickness of the media. Data were obtained at 25-mm Hg pressure steps between 0 and 200 mm Hg. To satisfy the constraints of incompressibility in an isovolumetric cylinder, the innermost structures must undergo larger deformations than the outermost structures. This manifests as thinning of the wall. Therefore, each experiment was performed twice: once with a vessel segment in its normal cylindrical configuration, and again with a contiguous vessel segment turned inside-out to form an inverted cylinder. The deformations of individual lamellae obtained in normal and inverted vessel segments were averaged to determine their extensions independent of location. Results showed that the extensibilities of the lamellae were equal at all 4 anatomic locations across the media, suggesting equal stiffnesses of the lamellae. Other studies were performed to examine the distribution of the circumferential retractions of the lamellae that occurs when a vessel is extended longitudinally. Results showed that circumferential retraction also was distributed uniformly across the wall. These findings demonstrate that the elastic lamellae behave uniformly in both the circumferential and longitudinal directions at different locations across the wall thickness. Because of the interlocked structure of the elastin, muscle, and collagen in the media, these findings suggest that although the media is histologically heterogeneous, it acts mechanically as a homogeneous material.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10082491&dopt=Abstract
Am J Physiol. 1999 Mar;276(3 Pt 1):G591-8.
Pronase destroys the lipopolysaccharide receptor CD14 on Kupffer cells.
Ikejima K, Enomoto N, Seabra V, Ikejima A, Brenner DA, Thurman RG.
Laboratory of Hepatobiology and Toxicology, Department of Pharmacology, University of North Carolina, Chapel Hill, North Carolina 27599-7365, USA.
CD14 is a lipopolysaccharide (LPS) receptor distributed largely in macrophages, monocytes, and neutrophils; however, the role of CD14 in activation of Kupffer cells by LPS remains controversial. The purpose of this study was to determine if different methods used to isolate Kupffer cells affect CD14. Kupffer cells were isolated by collagenase (0.025%) or collagenase-Pronase (0.02%) perfusion and differential centrifugation using Percoll gradients and cultured for 24 h before experiments. CD14 mRNA was detected by RT-PCR from Kupffer cell total RNA as well as from peritoneal macrophages. Western blotting showed that Kupffer cells prepared with collagenase possess CD14; however, it was absent in cells obtained by collagenase-Pronase perfusion. Intracellular calcium in Kupffer cells prepared with collagenase was increased transiently to levels around 300 nM by addition of LPS with 5% rat serum, which contains LPS binding protein. This increase in intracellular calcium was totally serum dependent. Moreover, LPS-induced increases in intracellular calcium in Kupffer cells were blunted significantly (40% of controls) when cells were treated with phosphatidylinositol-specific phospholipase C, which cleaves CD14 from the plasma membrane. However, intracellular calcium did not increase when LPS was added to cells prepared by collagenase-Pronase perfusion even in the presence of serum. These cells were viable, however, because ATP increased intracellular calcium to the same levels as cells prepared with collagenase perfusion. Tumor necrosis factor-alpha (TNF-alpha) mRNA was increased in Kupffer cells prepared with collagenase perfusion 1 h after addition of LPS, an effect potentiated over twofold by serum; however, serum did not increase TNF-alpha mRNA in cells isolated via collagenase-Pronase perfusion. Moreover, treatment with Pronase rapidly decreased CD14 on mouse macrophages (RAW 264.7 cells) and Kupffer cells. These findings indicate that Pronase cleaves CD14 from Kupffer cells, whereas collagenase perfusion does not, providing an explanation for why Kupffer cells do not exhibit a CD14-mediated pathway when prepared with procedures using Pronase. It is concluded that Kupffer cells indeed contain a functional CD14 LPS receptor when prepared gently.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10070034&dopt=Abstract
Oncogene. 1999 Mar 11;18(10):1837-44.
Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression.
Kon A, Vindevoghel L, Kouba DJ, Fujimura Y, Uitto J, Mauviel A.
Department of Dermatology and Cutaneous Biology, Jefferson Institute of Molecular Medicine, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
We have previously demonstrated that transforming growth factor-beta (TGF-beta) and pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) or interleukin-1beta, synergistically enhance the expression of type VII collagen gene (COL7A1) in human dermal fibroblasts in culture (Mauviel et al., 1994). Recently, we identified a SMAD-containing complex, rapidly induced by TGF-beta and binding the region [-496/-444] of the COL7A1 promoter, responsible for COL7A1 gene transactivation (Vindevoghel et al., 1998a). In this report, we demonstrate that TGF-beta and TNF-alpha response elements are distinct entities within the COL7A1 promoter. In particular, we demonstrate that the TNF-alpha effect is mediated by NF-kappaB1/RelA (p50/p65) and RelA/RelA (p65/p65) NF-kappaB complexes binding the TNF-alpha response element (TaRE) located in the region [-252/-230], with RelA acting as the transcriptional activator. Finally, we provide definitive evidence for the role of both TGF-beta and TNF-alpha response elements as enhancer sequences, functioning in the context of a heterologous promoter in an additive manner in response to TGF-beta and TNF-alpha. This study provides the first identification of a functional interaction between the two immediate-early transcription factors, SMAD and NF-kappaB, to activate the expression of an extracellular matrix-related gene, COL7A1.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10086338&dopt=Abstract
Gynecol Obstet Invest. 1999;47 Suppl 1:18-20; discussion 20-2.
Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model.
Matsuura K, Ohtake H, Katabuchi H, Okamura H.
Department of Obstetrics and Gynecology, Kumamoto University School of Medicine, Kumamoto, Japan.
Ultrastructure studies of pelvic peritoneal tissue from women undergoing laparotomy suggest that before endometriosis has become established in the peritoneum, there might be a metaplastic change by peritoneal mesothelial cells into endometrial glandular cells. A new in vitro experimental model of endometriosis using human ovarian surface epithelium cells has shown evidence that endometriotic lesions can arise by a process of metaplasia from the ovarian surface epithelium. In this model, when both ovarian surface epithelium and ovarian stromal cells were cocultured with 17beta estradiol in a three-dimensional collagen gel lattice, the ovarian surface epithelium cells formed a lumen structure, surrounded by endometrial stromal cells with an epithelial mesenchymal structure. Immunoreactivity for epithelial membrane antigen and cytokeratin was shown in the glandular cells and cilia, as well as in the microvilli. Electron microscopy showed evidence of tight junctions on cell surfaces. These findings suggest that endometriosis may manifest as a serial change from the adjacent mesothelial cells.
online pharmacy ref. source: www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10087424&dopt=Abstract
Prescription drugs, surgical hair transplantation, topical application of various oils or creams... Also prayer and wishing...
Anecdotes and personal experiences testify that it works. Hair Million shows positive results and improvement for age-related
hair thinning and hair loss for a large fraction of people who take it.
How does it work? Good question. The molecular biological or clinical mechanisms of action as to how Hair Million exactly works
to help stop hair loss, and promote hair growth is completely unknown.
The only evidences for the effecacy of Hair Million on hair growth are only anedotal and based on personal experiences.
There has been no clinical trials or placebo controlled statistical analysis on the efficacy of Hair Million on hair loss and hair growth.
That's enough for many people. Also, there are two merits in the hair restoration herbal formula:
Firstly, HairMillion is comparatively inexpensive, and secondly, it is made only of herbs
that are known to be safe when consumed in regular quantities. Herbs in Hair Million are also known for cardiotonic effects, meaning
that the herbs will make your heart stronger.
DHEA has been suggested to provide numerous potential benefits. DHEA (or dehydroepiandrosterone) is converted into androgens (male hormones)
or estrogens (female hormones) in the cells.
Natural Herbal Supplements||
Best Realtor in Glendale, California: Residential Home and Commercial Property ||
Related Web pages ||
Viagra ||
Herbs and Pharmaceuticals Online ||